Propanc Biopharma, Inc. filed its 10-K on Sep 28, 2022 for the period ending Jun 30, 2022. In this report its auditor, Salberg & Company, P.A., gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0016 USD | -3.03% | -11.11% | -86.67% |
1st Jan change | Capi. | |
---|---|---|
-86.67% | 302K | |
+18.12% | 125B | |
+13.16% | 108B | |
-7.43% | 24.21B | |
+1.83% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-12.77% | 16.37B | |
+1.00% | 13.58B | |
+26.48% | 11.66B |
- Stock Market
- Equities
- PPCB Stock
- News Propanc Biopharma, Inc.
- Propanc Biopharma, Inc. Auditor Raises 'Going Concern' Doubt